Theranostic applications of phage display to control leishmaniasis: Selection of biomarkers for serodiagnostics, vaccination, and immunotherapy

Phage display is a high-throughput subtractive proteomic technology used for the generation and screening of large peptide and antibody libraries. It is based on the selection of phage-fused surface-exposed peptides that recognize specific ligands and demonstrate desired functionality for diagnostic...

ver descrição completa

Detalhes bibliográficos
Autores: Goulart, Luiz Ricardo, Soto Álvarez, Manuel, Tavares, Carlos Alberto Pereira, Costa, Lourena Emanuele, Chávez-Fumagalli, Miguel Angel, Coelho, Eduardo Antonio Ferraz
Tipo de documento: artigo
Data de publicação:2015
País:España
Recursos:Universidad Autónoma de Madrid
Repositório:Biblos-e Archivo. Repositorio Institucional de la UAM
Idioma:inglês
OAI Identifier:oai:repositorio.uam.es:10486/675362
Acesso em linha:http://hdl.handle.net/10486/675362
https://dx.doi.org/10.1590/0037-8682-0096-2015
Access Level:Acceso aberto
Palavra-chave:Mimotopes
Phage display
Serodiagnosis
Vaccine
Visceral leishmaniasis
Biología y Biomedicina / Biología
Descrição
Resumo:Phage display is a high-throughput subtractive proteomic technology used for the generation and screening of large peptide and antibody libraries. It is based on the selection of phage-fused surface-exposed peptides that recognize specific ligands and demonstrate desired functionality for diagnostic and therapeutic purposes. Phage display has provided unmatched tools for controlling viral, bacterial, fungal, and parasitic infections, and allowed identification of new therapeutic targets to treat cancer, metabolic diseases, and other chronic conditions. This review presents recent advancements in serodiagnostics and prevention of leishmaniasis -an important tropical parasitic disease- achieved using phage display for the identification of novel antigens with improved sensitivity and specificity. Our focus is on theranostics of visceral leishmaniasis with the aim to develop biomarker candidates exhibiting both diagnostic and therapeutic potential to fight this important, yet neglected, tropical disease